Appendix 3B - Proposed issue of securities Update Summary Entity name NEURIZON THERAPEUTICS LIMITED Announcement Type Update to previous announcement Date of this announcement 16/11/2026 Reason for update to a previous announcement Maximum number of Options to be issued updated to 210,294,116....
Update - Proposed issue of securities - NUZ
Filed with ASX · · 5 pages · English
Summary by 6ix AI
The maximum number of options to be issued has been updated significantly from a previous announcement. The filing outlines the conditions required for the proposed issue, including shareholder approval and the expected timeline for the issuance. The options will be offered to participants under a placement and a share purchase plan, with specific terms for exercise and expiry.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Neurizon Therapeutics Limited on 6ix
Story so far
Earlier from Neurizon Therapeutics
- Notice of General Meeting/Proxy Form
- Prospectus
- Share Purchase Plan and Options Offer Open
- First Regimen I patient enters Active Treatment Extension
- R&D Facility Extension and Second Drawdown Completed
Later from Neurizon Therapeutics
All Neurizon Therapeutics news releasesFollow Neurizon Therapeutics into a list and get an email when it puts out news.
Follow Neurizon Therapeutics